TCTR20230530007尚未招募3 期
Efficacy and safety of tetracaine eye drops as a topical skin anesthesia in decreasing pain prior to botulinum toxin type A injections in blepharospasm patients
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Patients of age more than 18 years
- •2.Diagnosed with Blepharospasm both eye by experienced neuro-ophthalmologists
- •3.Received the latest BoNT-A injection for more than 3 months
排除标准
- •1.Allergic reaction to Botulinum toxin type A
- •2.Neuromuscular diseases
- •3.Any active infection in treatment area
- •4.Receiving anticoagulants
- •5.Diagnosed with bleeding disorders
- •6.Patients undergone prior facial cosmetic surgical procedure, such as eyebrow lift and others periorbital surgery
- •7.Patients with psychological disease
- •8.Patients with different severity of Blepharospasm
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety assessment of T4030 eye drops (unpreserved fixed combination of bimatoprost 0.01% and timolol 0.1% or 0.5%) versus Ganfort® UD (Unit Dose) in ocular hypertensive or glaucomatous patients.Glaucoma, ocular hypertensionMedDRA version: 20.0Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersEUCTR2017-002823-46-ATaboratoires THÉA; Research and Development Department143
进行中（未招募）
1 期
Efficacy and safety assessment of T4030 eye drops (unpreserved fixed combination of bimatoprost 0.01% and timolol 0.1% or 0.5%) versus Ganfort® UD (Unit Dose) in ocular hypertensive or glaucomatous patients.Glaucoma, ocular hypertensionMedDRA version: 20.0 Level: HLGT Classification code 10018307 Term: Glaucoma and ocular hypertension System Organ Class: 10015919 - Eye disordersEUCTR2017-002823-46-HUaboratoires THÉA; Research and Development Department108
进行中（未招募）
1 期
Efficacy and safety assessment of T4030 eye drops (unpreserved fixed combination of bimatoprost 0.01% and timolol 0.1% or 0.5%) versus Ganfort® UD (Unit Dose) in ocular hypertensive or glaucomatous patients.Glaucoma, ocular hypertensionMedDRA version: 20.0Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersEUCTR2017-002823-46-BEaboratoires THÉA; Research and Development Department143
进行中（未招募）
1 期
Efficacy and Safety Assessment of T4030 Eye Drops versus Ganfort® UDin Ocular Hypertensive or Glaucomatous Patients.EUCTR2020-003979-18-HUaboratoires THEA500
进行中（未招募）
1 期
Efficacy and Safety Assessment of T4030 Eye Drops versus Ganfort® UDin Ocular Hypertensive or Glaucomatous Patients.Primary open-angle glaucoma or Ocular hypertensionMedDRA version: 20.0Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersEUCTR2020-003979-18-FRaboratoires THEA500